SCHEMBL13136409

SCHEMBL13136409

CN1C(=O)c2ccccc2C1(CO)CO

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 6/20 0.44
ALDH1A1 P00352 3/20 0.43
CYP2D6 P10635 3/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP3A4 P08684 1/20 0.40
PGR P06401 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HRH3 Q9Y5N1 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PARP1 P09874 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13788869 0.92 MDM2 (0.45) MDM2ALDH1A1CYP2D6MEN1CYP1A2
SCHEMBL13136403 0.90 CYP2D6 (0.43) MDM2ALDH1A1CYP2D6MEN1CYP1A2
SCHEMBL11362057 0.78 ALDH1A1 (0.40) MDM2ALDH1A1CYP2D6MEN1CYP1A2
SCHEMBL1948836 0.77 PGR (0.47) MDM2ALDH1A1CYP2D6MEN1CYP1A2
SCHEMBL2597754 0.77 ALDH1A1 (0.42) MDM2ALDH1A1CYP2D6MEN1CYP1A2
SCHEMBL2599307 0.77 ALDH1A1 (0.42) MDM2ALDH1A1CYP2D6MEN1CYP1A2
SCHEMBL2599267 0.77 ALDH1A1 (0.42) MDM2ALDH1A1CYP2D6MEN1CYP1A2
SCHEMBL13136413 0.74 ELANE (0.39) MDM2ALDH1A1CYP2D6MEN1CYP1A2
SCHEMBL2597761 0.71 ATM (0.41) MDM2ALDH1A1MEN1CYP1A2KMT2A
SCHEMBL2597994 0.71 ATM (0.41) MDM2ALDH1A1MEN1CYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790832-B2 Methods for purifying 2-aryl-3,3-bis(hydroxyaryl)phthalimidines SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-09-07 US disclosed
US-7563817-B2 Purified 2-aryl-3,3-bis(hydroxyaryl)phthalimidines SABIC INNOVATIVE PLASTICS IP BV (NL) 2009-07-21 US disclosed
US-7348439-B2 2-aryl-3-(aminoaryl)-3-(hydroxyaryl)phthalimidine compounds and methods for making them GENERAL ELECTRIC COMPANY (US) 2008-03-25 US disclosed
US-20070197761-A1 2-ARYL-3-(AMINOARYL)-3-(HYDROXYARYL)PHTHALIMIDINE COMPOUNDS AND METHODS FOR MAKING THEM GENERAL ELECTRIC COMPANY (US) 2007-08-23 US disclosed
US-20070135612-A1 Methods for purifying 2-aryl-3,3-bis(hydroxyaryl)phthalimidines SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2007-06-14 US disclosed
US-20070123714-A1 2-ARYL-3-(AMINOARYL)-3-(HYDROXYARYL)PHTHALIMIDINE COMPOUNDS AND METHODS FOR MAKING THEM SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197761-A1 2-ARYL-3-(AMINOARYL)-3-(HYDROXYARYL)PHTHALIMIDINE COMPOUNDS AND METHODS FOR MAKING THEM AHR, ARNT, AR MDM2 83/4885ALDH1A1 38/4885CYP2D6 87/4885
US-20070123714-A1 2-ARYL-3-(AMINOARYL)-3-(HYDROXYARYL)PHTHALIMIDINE COMPOUNDS AND METHODS FOR MAKING THEM AHR, ARNT, AR MDM2 83/4885ALDH1A1 38/4885CYP2D6 87/4885
US-20070135612-A1 Methods for purifying 2-aryl-3,3-bis(hydroxyaryl)phthalimidines AHR, ARSA, CBR1 MDM2 278/4885ALDH1A1 50/4885CYP2D6 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.